Литература /references
1. Yoshizawa J.M., Schafer C.A., Schafer J.J., Farrell J.J. et al. Salivary biomarkers: toward future clinical and diagnostic utilities. Clin Microbiol Rev. 2013; Vol. 26 (4): 781-91.
2. Gupta S., Venkatesh A., Ray S., Srivastava S. Challenges and prospects for biomarker research: a current perspective from the developing world. Biochim Biophys Acta. 2014; Vol. 1844 (5): 899-908.
3. Wagner P.D., Verma M., Srivastava S. Challenges for biomarkers in cancer detection. Ann N.Y. Acad Sci. 2004; Vol. 1022: 9-16.
4. Dogan U.B., Akin M.S., Yalaki S. Alanine aminotransferase normalization at week 8 predicts viral response during hepatitis C treatment. World J Gastroenterol. 2013; Vol. 19 (46): 8678-86.
5. Ray S., Patel S.K., Kumar V., Damahe J. et al. Differential expression of serum/plasma proteins in various infectious diseases: specific or nonspecific signatures. Proteomics Clin Appl. 2014; Vol. 8 (1-2): 53-72.
6. Chakera A., Lucas A., Lucas M. Surrogate markers of infection: interrogation of the immune system. Biomark Med. 2011; Vol. 5 (2): 131-48.
7. Nishida H. Biomarkers for neural injury and infection in small animals. Vet Clin North Am Small Anim Pract. 2014; Vol. 44 (6): 1187-99.
8. Kurian S., Grigoryev Y., Head S., Campbell D. et al. Applying genomics to organ transplantation medicine in both discovery and validation of biomarkers. Int Immunopharmacol. 2007; Vol. 7 (14): 1948-60.
9. Bonassi S., Neri M., Puntoni R. Validation of biomarkers as early predictors of disease. Mutat Res. 2001; Vol. 480-481: 349-58.
10. Page A.V., Liles W.C. Biomarkers of endothelial activation/dysfunction in infectious diseases. Virulence. 2013; Vol. 4 (6): 507-16.
11. Yeh Y.T., Nisic M., Yu X., Xia Y. et al. Point-of-care microdevices for blood plasma analysis in viral infectious diseases. Ann Biomed Eng. 2014; Vol. 42 (11): 2333-43.
12. Burbelo P.D., Bayat A., Lebovitz E.E., Iadarola M.J. New technologies for studying the complexity of oral diseases. Oral Dis. 2012; Vol. 18 (2): 121-6.
13. Amado L.A., Villar L.M., de Paula V.S., de Almeida A.J. et al. Detection of hepatitis A, B, and C virus-specific antibodies using oral fluid for epidemiological studies. Mem Inst Oswaldo Cruz. 2006; Vol. 101 (2): 149-55.
14. Mager D., Haffajee A., Devlin P., Norris C. et al. The salivary microbiota as a diagnostic indicator of oral cancer: a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects. J Transl Med. 2005; Vol. 3: 27-34.
15. Sakushima K., Yabe I., Sasaki H. Revival of old diagnostic markers in the cerebrospinal fluid for the detection of infectious meningitis. Rinsho Shinkeigaku. 2012; Vol. 52 (1): 6-11.
16. Lam C.W., Law C.Y., Sze K.H., To K.K. Quantitative metabolomics of urine for rapid etiological diagnosis of urinary tract infection: Evaluation of a microbial-mammalian cometabolite as a diagnostic biomarker. Clin Chim Acta. 2014; Vol. 438: 24-8.
17. Brecher S.M., Novak-Weekley S.M., Nagy E. Laboratory diagnosis of Clostridium difficile infections: there is light at the end of the colon. Clin Infect Dis. 2013; Vol. 57 (8): 1175-81.
18. McNerney R., Maeurer M., Abubakar I., Marais B. et al. Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J Infect Dis. 2012; Vol. 205 (suppl. 2): 147-58.
19. Bowden G.H. Does assessment of microbial composition of plaque/saliva allow for diagnosis of disease activity of individuals? Community Dent Oral Epidemiol. 1997; Vol. 25 (1): 76-81.
20. Lazarevic V., Whiteson K., Gaia N., Gizard Y. et al. Analysis of the salivary microbiome using culture-independent techniques. J Clin Bioinformatics. 2012; Vol. 2: 4-11.
21. Lecuit M., Eloit M. The diagnosis of infectious diseases by whole genome next generation sequencing: a new era is opening. Front Cell Infect Microbiol. 2014; Vol. 4: 25-7.
22. Clark J.E. Determining the microbiological cause of a chest infection. Arch Dis Child. 2014. pii: archdischild-2013-305742.
23. Elemraid M.A., Rushton S.P., Thomas M.F., Spencer D.A. et al. Changing clinical practice: management of paediatric communityacquired pneumonia. J Eval Clin Pract. 2014; Vol. 20 (1): 94-9.
24. Slezak T. Bacterial genome reference databases: progress and challenges. PDA J Pharm Sci Technol. 2014; Vol. 68 (6): 619.
25. Chang S.S., Hsieh W.-H., Liu T.S., Lee S.H. et al. Multiplex PCR system for rapid detection of pathogens in patients with presumed sepsis - a systemic review and meta-analysis. PLoS One. 2013; Vol. 8. Article ID: e62323.
26. Dabisch-Ruthe M., Vollmer T., Adams O., Knabbe C. et al. Comparison of three multiplex PCR assays for the detection of respiratory viral infections: evaluation of xTAG respiratory virus panel fast assay, RespiFinder 19 assay and RespiFinder smart 22 assay. BMC Infect Dis. 2012; Vol. 12: 163-73.
27. Reuter S., Ellington M.J., Cartwright E.J., Köser C.U. et al. Rapid bacterial whole-genome sequencing to enhance diagnostic and public healthmicrobiology. JAMA Intern Med. 2013; Vol. 173 (15): 1397-404.
28. Wang Z., Li X., Shi C., Zhang M. et al. Screening for serum biomarkers in patients with chronic hepatitis B with hepatitis B surface antigen seroclearance, following pegylated interferon alpha therapy. Mol Med Rep. 2015; Vol. 11 (1): 427-33.
29. Hashoosh D.A., Majeed I.A. Comparison of two assays in the diagnosis of toxoplasmosis: immunological and molecular. East Mediterr Health J. 2014; Vol. 20 (1): 46-50.
30. Solis Garcia Del Pozo J., Lorente Ortuño S., Navarro E., Solera J. Detection of IgM Antibrucella Antibody in the Absence of IgGs: A Challenge for the Clinical Interpretation of Brucella Serology. PLoS Negl Trop Dis. 2014; Vol. 8 (12). Article ID: e3390.
31. Fick R.B. Lung humoral response to Pseudomonas species. Eur J Clin Microbiol Infect Dis. 1989; Vol. 8 (1): 29-34.
32. Gutierrez Diez F.J., Blanco Quiros A., Ponce Ortega A., Garrote Adrados J.A. IgG subclass antibodies in children of Vallidolid. Low materno-fetal protection. An Esp Pediatr. 1991; Vol. 34 (1): 19-24.
33. Bhattacharyya T., Ayandeh A., Falconar A.K., Sundar S. et al. IgG1 as a рotential biomarker of рost-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test. PLoS Negl Trop Dis. 2014; Vol. 8 (10). Article ID: e3273.
34. Adler M., Wacker R., Niemeyer C.M. Sensitivity by combination: immuno-PCR and related technologies. Analyst. 2008; Vol. 133 (6): 702-18.
35. Mehta P.K., Raj A., Singh N.P., Khuller G.K. Detection of potential microbial antigens by immuno-PCR (PCR-amplified immunoassay). J Med Microbiol. 2014; Vol. 63 (Pt 5): 627-41.
36. Loeb M. Host genomics in infectious diseases. Infect Chemother. 2013; Vol. 45 (3): 253-9.
37. Horby P., Sudoyo H., Viprakasit V., Fox A. et al. What is the evidence of a role for host genetics in susceptibility to influenza A/H5N1? Epidemiol Infect. 2010; Vol. 138 (11): 1550-8.
38. Roy S., Frodsham A., Saha B., Hazra S.K. et al. Association of vitamin D receptor genotype with leprosy type. J Infect Dis. 1999; Vol. 179: 187-91.
39. Tanaka Y., Nishida N., Sugiyama M. et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 2009; Vol. 41 (10): 1105-9.
40. Bellamy R., Ruwende C., Corrah T., McAdam K.P. et al. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene. J Infect Dis. 1999; Vol. 179: 721-4.
41. Loeb M., Eskandarian S., Rupp M., Fishman N. et al. Genetic variants and susceptibility to neurological complications following West Nile virus infection. J Infect Dis. 2011; Vol. 204: 1031-7.
42. Heyn H. A symbiotic liaison between the genetic and epigenetic code. Front Genet. 2014; Vol. 5: 113-8.
43. Hnisz D., Abraham B.J., Lee T.I., Lau A. et al. Superenhancers in the control of cell identity and disease. Cell. 2013; Vol. 155 (4): 934-47.
44. Ziller M.J., Gu H., Muller F., Donaghey J. et al. Charting a dynamic DNA methylation landscape of the human genome. Nature. 2013; Vol. 500 (7463): 477-81.
45. Paul D.S., Albers C.A., Rendon A., Voss K. et al. Maps of open chromatin highlight cel ltype-restricted patterns of regulatory sequence variation at hematological trait loci. Genome Res. 2013; Vol. 23: 1130-41.
46. Ohgane J., Yagi S., Shiota K. Epigenetics: the DNA methylation profile of tissue-dependent and differentially methylated regions in cells. Placenta. 2008; Vol. 29 (suppl. A): 29-35.
47. Bocklandt S., Lin W., Sehl M.E., Sanchez F. et al. Epigenetic predictor of age. PLoS One. 2011; Vol. 6 (6). Article ID: e14821.
48. Lee H., Park M., Choi A., An J. et al. Potential forensic application of DNA methylation profiling to body fluid identification. Int J Legal Med. 2012; Vol. 126 (1): 55-62.
49. Zilbauer M., Rayner T.F., Clark C., Coffey A.J. et al. Genomewide methylation analyses of primary human leukocyte subsets identifies functionally important cell-type-specific hypomethylated regions. Blood. 2013; Vol. 122 (25): 52-60.
50. Pinto R., De Summa S., Petriella D., Tudoran O. et al. The value of new high-throughput technologies for diagnosis and prognosis in solid tumors. Cancer Biomark. 2014; Vol. 14 (2-3): 103-17.
51. Kim H.Y., Kim H.R., Lee S.H. Advances in systems biology approaches for autoimmune diseases. Immune Netw. 2014; Vol. 14 (2): 73-80.
52. Rue-Albrecht K., Magee D.A., Killick K.E., Nalpas N.C. et al. Comparative functional genomics and the bovine macrophage response to strains of the Mycobacterium genus. Front Immunol. 2014; Vol. 5: 536-49.
53. Feghaly R.E., Stauber J.L., Tarr P.I., Haslam D.B. Intestinal inflammatory biomarkers and outcome in pediatric Clostridium difficile infections. J Pediatr. 2013; Vol. 163 (6): 1697-704.
54. Bhaskaran M., Mohan M. MicroRNAs: history, biogenesis, and their evolving role in animal development and disease. Vet Pathol. 2013; Vol. 51 (4): 759-74.
55. Fowler L., Saksena N.K. Micro-RNA: new players in HIVpathogenesis, diagnosis, prognosis and antiviral therapy. AIDS Rev. 2013; Vol. 15 (1): 3-14.
56. Dahiya N., Atreya C.D. MicroRNAs and major blood-borne infectious viral diseases. Microrna. 2014; Vol. 2 (3): 212-8.
57. Huang C., Zheng J.M., Cheng Q., Yu K.K. et al. Serum microRNA-29 levels correlate with disease progression in patients with chronic hepatitis B virus infection. J Dig Dis. 2014; Vol. 15 (11): 614-21.
58. Wang J.Y., Mao R.C., Zhang Y.M., Zhang Y.J. et al. Serum microRNA-124 is a novel biomarker for liver necroinflammation in patients with chronic hepatitis B virus infection. J Viral Hepat. 2014; Vol. 22 (2): 128-36.
59. Wei Y.F., Cui G.Y., Ye P., Chen J.N. et al. MicroRNAs may solve the mystery of chronic hepatitis B virus infection. World J Gastroenterol. 2013; Vol. 19 (30): 4867-76.
60. Kawano Y., Iwata S., Kawada J., Gotoh K. et al. Plasma viral microRNA profiles reveal potential biomarkers for chronic active Epstein-Barr virus infection. J Infect Dis. 2013; Vol. 208 (5): 771- 9.
61. Manzano-Roman R., Siles-Lucas M. MicroRNAs in parasitic diseases: potential for diagnosis and targeting. Mol Biochem Parasitol. 2012; Vol. 186 (2): 81-6.
62. Mavromati J., Cash P., Restelli L., Soler L. Proteomics and protein analyses of ovine and caprine body fluids: current studies and future promises. Curr Protein Pept Sci. 2014; Vol. 15 (1): 45- 55.
63. Fairfax M.R., Salimnia H. Diagnostic molecular microbiology: a 2013 snapshot. Clin Lab Med. 2013; Vol. 33 (4): 787-803.
64. Tanca A., Deligios M., Addis M.F., Uzzau S. High throughput genomic and proteomic technologies in the fight against infectious diseases. J Infect Dev Ctries. 2013; Vol. 7 (3): 182-90.
65. Bregnard C., Zamborlini A., Leduc M., Chafey P. et al. Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity. J Virol. 2013; Vol. 87 (7): 3729-40.
66. Nguyen E.V., Gharib S.A., Crothers K., Chow Y.H. et al. Proteomic landscape of bronchoalveolar lavage fluid in human immunodeficiency virus infection. Am J Physiol Lung Cell Mol Physiol. 2014; Vol. 306 (1): 35-42.
67. Chen J.H., Yam W.C., Ngan A.H., Fung A.M. et al. Advantages of using matrix-assisted laser desorption ionization-time of flight mass spectrometry as a rapid diagnostic tool for identification of yeasts and mycobacteria in the clinical microbiological laboratory. J Clin Microbiol. 2013; Vol. 51 (12): 3981-7.
68. Reyda S., Buscher N., Tenzer S., Plachter B. Proteomic analyses of human cytomegalovirus strain AD169 derivatives reveal highly conserved patterns of viral and cellular proteins in infected fibroblasts. Viruses. 2014; Vol. 6 (1): 172-88.
69. Ratcliffe P., Fang H., Thidholm E., Borang S. et al. Comparison of MALDI-TOF MS and VITEK 2 system for laboratory diagnosis of Granulicatella and Abiotrophia species causing invasive infections. Diagn Microbiol Infect Dis. 2013; Vol. 77 (3): 216-9.
70. Ding Y., Li X.R., Yang K.Y., Huang L.H. et al. Proteomics analysis of gastric epithelial AGS cells infected with Epstein-Barr virus. Asian Pac J Cancer Prev. 2013; Vol. 14 (1): 367-72.
71. Zhang L.K., Chai F., Li H.Y., Xiao G. et al. Identification of host proteins involved in Japanese encephalitis virus infection by quantitative proteomics analysis. J Proteome Res. 2013; Vol. 12 (6): 2666-78.
72. Chattopadhyay S., Basak T., Nayak M.K., Bhardwaj G. et al. Identification of cellular calcium binding protein calmodulin as a regulator of rotavirus Ainfection during comparative proteomic study. PLoS One. 2013; Vol. 8 (2). Article ID: e56655.
73. Deng L., Jia H.L., Liu C.W., Xu Y.F. et al. Proteomic analysis of extremely severe hand, foot and mouth disease infected by enterovirus 71. BMC Infect Dis. 2013; Vol. 13: 383-90.
74. Camargo J.F., Husain S. Immune correlates of protection in human invasive aspergillosis. Clin Infect Dis. 2014; Vol. 59 (4): 569-77.
75. Wujcicka W., Wilczyński J., Nowakowska D. Alterations in TLRs as new molecular markers of congenital infections with Human cytomegalovirus? Pathog Dis. 2014; Vol. 70 (1): 3-16.
76. Bhadra R., Cobb D.A., Khan I.A. CD40 signaling to the rescue: A CD8 exhaustion perspective in chronic infectious diseases. Crit Rev Immunol. 2013; Vol. 33 (4): 361-78.
77. Li S., Huang X., Chen Z., Zhong H. et al. Neutrophil CD64 expression as a biomarker in the early diagnosis of bacterial infection: a meta-analysis. Int J Infect Dis. 2013; Vol. 17 (1): 12-23.
78. Lee H. Procalcitonin as a biomarker of infectious diseases. Korean J Intern Med. 2013; Vol. 28 (3): 285-91.
79. Holub M., Lawrence D.A., Andersen N., Davidova A. et al. Cytokines and chemokines as biomarkers of community-acquired bacterial infection. Mediators Inflamm. 2013. pii: 190145-51.
80. Cho S.-Y., Choi J.-H. Biomarkers of sepsis. Infect Chemother. 2014; Vol. 46 (1): 1-12.
81. John S.H., Kenneth J., Gandhe A.S. Host biomarkers of clinical relevance in tuberculosis: review of gene and protein expression studies. Biomarkers. 2012; Vol. 17 (1): 1-8.
82. Andrade B.B., Hullsiek K.H., Boulware D.R., Rupert A. et al. Biomarkers of inflammation and coagulation are associated with mortality and hepatitis flares in persons coinfected with HIV and hepatitis viruses. J Infect Dis. 2013; Vol. 207 (9): 1379-88.
83. Nagana Gowda G.A., Gowda Y.N., Raftery D. Expanding the limits of Human Blood Metabolite Quantitation using NMR spectroscopy. Anal Chem. 2015; Vol. 87 (1): 706-15.
84. Holmes E., Nicholson J.K. Human metabolic phenotyping and metabolome wide association studies. Ernst Schering Found Symp Proc. 2007; Vol. 4: 227-49.
85. Semmo N., Weber T., Idle J.R., Beyo lu D. Metabolomics reveals that aldose reductase activity due to AKR1B10 is upregulated in hepatitis C virus infection. J Viral Hepat. 2015; 22 (7): 617-24.
86. Roe B., Kensicki E., Mohney R., Hall W.W. Metabolomic profile of hepatitis C virus-infected hepatocytes. PLoS One. 2011; Vol. 6 (8). Article ID: e23641.
87. Kok M.G., Somsen G.W., de Jong G.J. Comparison of capillary electrophoresis-mass spectrometry and hydrophilic interaction chromatography-mass spectrometry for anionic metabolic profiling of urine. Talanta. 2015; Vol. 132: 1-7.
88. Shin J.H., Yang J.Y., Jeon B.Y., Yoon Y.J. et al. (1)H NMRbased metabolomic profiling in mice infected with Mycobacterium tuberculosis. J Proteome Res. 2011; Vol. 10 (5): 2238-47.
89. Xu W., Chen D., Wang N., Zhang T. et al. Development of high-performance chemical isotope labeling LC-MS for profiling the human fecal metabolome. Anal Chem. 2015; Vol. 87 (2): 829-36.
90. Theriot C.M., Koenigsknecht M.J., Carlson P.E. Jr, Hatton G.E. et al. Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection. Nat Commun. 2014; Vol. 5: 3114-32.
91. Ktsoyan Z.A., Beloborodova N.V., Sedrakyan A.M., Osipov G.A. et al. Profiles of microbial fatty acids in the human metabolome are disease-specific. Front Microbiol. 2011; Vol. 1: 148-56.
92. Zhang B., Powers R. Analysis of bacterial biofilms using NMR-based metabolomics. Future Med Chem. 2012; Vol. 4 (10): 1273-306.
93. Chung J.H., Park Y.S., Kim J., Shin G.W. et al. Parallel analysis of antimicrobial activities in microbial community by SSCP based on CE. Electrophoresis. 2007; Vol. 28 (14): 2416-23.
94. Kauko T., Haukka K., Abuoun M., Anjum M.F. et al. Phenotype MicroArray in the metabolic characterisation of Salmonella serotypes Agona, Enteritidis, Give, Hvittingfoss, Infantis, Newport and Typhimurium. Eur J Clin Microbiol Infect Dis. 2010; Vol. 29 (3): 311-7.
95. Lv H., Hung C.S., Henderson J.P. Metabolomic analysis of siderophore cheater mutants reveals metabolic costs of expression in uropathogenic Escherichia coli. J Proteome Res. 2014; Vol. 13 (3): 1397-404.